2m 2m 2m 2m 2m 2m 2m
TREACE MED CNCPT (TMCI)
NASDAQ
$5.05+$0.17 (+3.48%)
Price as of Nov 11, 2026 7:55 PM EST- $319.9MMarket Cap
- 45.24%1-Year Change
- Medical DevicesIndustry
TREACE MED CNCPT (TMCI)
$5.05+$0.17 (+3.48%)
TMCI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.88 | ||
Change | +$0.10 (+2.09%) | ||
Open | $4.78 | ||
High | $5.15 | ||
Low | $4.67 | ||
Previous Close | $4.78 | ||
Volume | 580,753 | ||
30-Day Average Volume | 285,112 | ||
1-Week Change | 14.02% | ||
1-Month Change | 23.54% | ||
1-Year Change | 45.24% | ||
3-Year Change | -21.42% | ||
5-Year Change | -77.09% | ||
Fundamentals | |||
Shares Outstanding | 65.6M | ||
Total Assets | $179.3M | ||
Market Cap | $319.9M | ||
Enterprise Value | $372.2M | ||
Period: QTR TTM FY | |||
Revenue | $48.3M | ||
Net Income | -$12.6M | ||
Free Cash Flow | -$5.4M | ||
EBIT | -$11.0M | ||
EBITDA | -$8.9M | ||
Net Working Capital | $72.6M | ||
EPS | -$0.19 | ||
Enterprise Value/EBITDA | -42 | ||
Enterprise Value/Revenue | 8 | ||
P/B | 5 | ||
P/E | -26 | ||
PEG | -1 | ||
Price/Free Cash Flow | -59 | ||
Price/Operating Cash Flow | -98 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue